Technological innovation is advancing at an ever-increasing pace. Over the past decade, global research and development (R&D) spending, a pivotal driver of technological innovation, has grown from 2.00% of GDP to 2.63%. After over a century of combined effort, 100 million patents were filed as of 2017, serving as the legal proof of technological innovation. This number is expected to double within the next ten years. While the realm of innovation encompasses a wide array of individuals, organizations, and institutions, it is undeniable that a significant portion of groundbreaking innovations can be attributed to a select group of tech companies.

Patsnap releases our very first Global Innovation Report, to identify and celebrate these innovation frontrunners, built on our proprietary “Innovation Capability Evaluation Model”. We identify and celebrate both the world’s top innovators, the Global Innovation 100, who have consistently pushed the boundaries of technology, and the rising Global Disruption 50, young companies who have developed remarkable technology capabilities, bringing disruptive change to the world. These global innovators and disruptors together represent the dynamic landscape of innovation, shaping the future of technology across a diverse array of industries.

Beyond the identification of these companies, we also illustrate some insights into the essence of their innovation. The Global Innovation 100 and Global Disruption 50 are not just 150 individual companies, each of them represents a small innovation ecosystem as there can be hundreds of subsidiaries within each organization. Together they represent the dynamic landscape of innovation, shaping the future of technology across a diverse array of industries.

Jump to…

Who are the 2023 Global Innovation 100?

Who are the 2023 Global Disruption 50?

Innovation is Deeply Interconnected

Methodology Behind the Report

Who are the 2023 Global Innovation 100?

The Global Innovation 100 are the greatest innovators of this era. Over the years, they have led the world’s technology progress, and consistently outperform others in technology innovation.  They are also trailblazers in the innovation ecosystem. They exert a profound influence on companies both within and beyond their respective industries, propelling the advancement of our times.

In the 2023 list, the 100 tech giants demonstrate distinctive capability in all the four technology dimensions. They have a huge technology size with outstanding technology quality, radiating profound technology influence, and a high degree of technology globalization.

Each company also has its own technology characteristics. For example, Samsung Electronics has the largest technology size, who filed a total of 884K patents. Johnson & Johnson outperforms all the others in terms of technology influence, whose patents are totally cited at 6.6M times high. In terms of technology globalization, Huawei has 64K PCT patent filings, and Pfizer’s patents cover a staggering 138 countries and regions – both are top among the 100 companies.

The Global Innovation 100 contribute to a quarter of the World’s technology innovation. Together, they are holding 3.58M valid inventions, which accounts for 22% of the world’s total technology assets. While in terms of technology globalization, they totally filed 1.27M PCT patents, indicating a 27% presence in the international technology competition. Most important of all, their patents are cited 153M total times, contributing to as much as 35% of the world’s technology inspiration. Despite these impressive innovation numbers, these 100 companies, alongside with their 68K tech subsidiaries, they account for less than 2% of the world’s total number of tech companies.

The Global Innovation 100 come from a variety of regions and industries. These top innovators come from 11 industries, 70% of them falling in Life Science & Healthcare, Chemicals & Materials, Electronics and Machinery & Equipment. Among them, Asian companies has a higher percentage in Chemical & Materials, Electronics and Machinery & Equipment, while their American and European counterparts have particularly strong presence in Life Science & Healthcare. In terms of geographical distribution, they come from 15 countries/regions. But in terms of patent applications, their technology footprints spread over the world.

Although showing signs of a slowing pace of innovation, the Global Innovation 100 are taking active steps to develop cutting-edge technologies. They have an average technology growth rate of -2.3% over recent years, slightly lower than overall global technology growth and economic growth. Only one in five of the 100 companies listed has maintained positive growth. But they are also gaining strong growth on some cutting-edge fields, such as smart grids and biomedical engineering. These “high-growth” tech subsidiaries are mainly concentrated in Asia and the U.S.. Both in-house incubation and external acquisition are used to build their portfolios.

Who are the 2023 Global Disruption 50?

The Global Disruption 50 are highly ambitious companies that demonstrate disruptive innovation capabilities and keep growing fast. They often lead to awe-inspiring breakthroughs and bring about disruptive changes in the established world, inspiring new possibilities. They have the potential to become future Global Innovation 100 members. We use our proprietary Model to select those top performers, with important restrictions of being “young” and “active”.

In the 2023 list, we see those young pursuers demonstrate vigorous ambition and significant progress. Founded between 2009-2019, these organizations have built up an astonishing technology competitiveness in less than 15 years. They also exhibit a high growth rate with an average patent application CAGR of 51%. 

Despite their relatively modest size and limited global coverage, these organizations are already showcasing a potent technological influence. A typical Disruption 50 company has only about 3600 patent applications, 2% of the size of an Innovation 100 company. They are also far less globalized, since their technologies only touch averagely 19 countries or regions, merely 1/4 of the average of Innovation 100. However, each of its patents receive 8.3 citations, almost equal to that of a Global Innovation 100 company. Top technology influencers include Snap, Kioxia, Cerence, Stripe etc., whose top 10 cited patents are cited 300-600 times on the average.

The Global Disruption 50 companies mostly come from the U.S. and China. The U.S. maintains a dominant position, accounting for half of the list. And most of them are focusing on Information Technology and Life Science & Healthcare. China is rapidly advancing with 20 companies, particularly in High-Tech Manufacturing, a strong contrast to its relatively weak presence in Global Innovation 100. Other 5 companies come from Japan, Australia, U.K., Ireland and Netherlands, one in each country.

From the Global Innovation 100 to the Global Disruption 50, the world’s innovation is shifting from a physical “world of Atoms”, to a digital “world of Bits”, and even a “world of Atoms empowered by Bits”. Nearly 30% of the Global Disruption 50 companies are from the IT domain. While DoorDash provides online food delivery services in the U.S., Lyft provides online shared transport services. And Zoom is reinventing the conventional teleconference with revolutionary online tools. Many participants from other industries are also offering solutions integrating physical products and digital services. For example, Peloton Interactive is a game-changer in the fitness sector providing workout equipment as well as software and platforms. Pateo is the end-to-end solution provider for the Internet of vehicles from automotive electronics and software to operating systems.

Innovation is Deeply Interconnected

The abundant tech data behind the Global Innovation 100 and Global Disruption 50 also sheds light on the overall landscape of innovation. We can clearly see that innovation is deeply interconnected.

Innovation collaboration is Ubiquitous. The Global Innovation 100 collaborate closely with each other in R&D. 99 out of the Global Innovation 100 participants have collaborated on technology innovation with others from the list. And each global innovative leader has averagely 26 partners in the list. Jointly, they have filed a staggering 85K patents. Those with the most partners are Panasonic, Siemens and Hitachi, each with around 50 partners. While those with the most joint patent applications are Toyota, Denso and Hitachi, each with more than 10K joint patent applications.

Interestingly, these tech giants also demonstrate different collaboration preferences. The U.S.’s 36 companies among Global Innovation 100 are more inclined to file joint patent applications with their overseas counterparts. Their joint patent applications with domestic counterparts are 40% of that with overseas counterparts. By contrast, the Japanese ones prefer cooperating with domestic counterparts, their joint patent applications with domestic counterparts being 6 times that of overseas ones. When we take a closer look at the top 10 technology partners of Global Innovation 100, 9 pairs out of 10 are from Japan. The top pair are Toyota and Denso. Denso, as a former subsidiary of Toyota, continues to technologically cooperate with Toyota after its spinoff. The 2 companies have jointly filed as many as 13K patent applications with each other. Additionally, Toyota Motor and Sumitomo Electric have more than 2K joint patent applications, and so do NEC and Fujitsu. Only 1 pair is from the U.S, namely, Abbott and AbbVie, who have jointly filed 1.2K patent applications.

The Global Disruption 50 participants also have strong relationship with the Global Innovation 100. 5 out of the 50 companies are spinoff from other well-established tech giants, some of which are even among the Innovation 100. For example, Resideo and Advansix are both spin-offs from Honeywell, one of the 2023 Global Innovation 100 companies. Kioxia, the Japanese semiconductor leader, inherited the core semiconductor technology of nearly 20K patents from its former parent company Toshiba, who is also one of this year’s Global Innovation 100. With the “legacies” they have inherited from their former owners, these companies have obtained unique technology advantages from day one, and they continue to make technology breakthroughs.

Methodology Behind the Report

Patsnap’s annual Global innovation report is constructed based on Company Innovation Capability Evaluation Model. The model includes 1+4 dimensions, namely, 1 enterprise competitiveness dimension and 4 technology dimensions, i.e., Technology Size, Technology Quality, Technology Influence and Technology globalization. Integrating all the 40+ indicators up, each tech company has a final score of innovation capability.

Based on the model, we keep evaluating innovation capability of the ~100 million tech companies all over the world, as well as their comprehensive innovation metrics, with a complex calculation of the ~180 million patents behind them.

In the report, we use the model to select the top performers as this year’s “Global Innovation 100”. And for “Global Disruption 50”, we keep the top performance as the core criteria, while adding 2 restrictive conditions of being “young” and “active”: they should be less than 15 years since founding, and their patent growth in past 3 years should have an annual growth rate of at least 10%.

It should be noted that all the companies listed are independent, not subsidiaries of any other company.

Enhance your understanding of global innovation by delving into the full report.

The post Patsnap Releases 2023 Global Innovation Report: The Brilliant Names to the Dynamic Landscape of Innovation appeared first on Patsnap.

Disrupting the Established World:

Global Presence and Industry Focus:

The 2023 Global Disruption 50, hailing from 10 countries, are distributed across 10 industries. The Information Technology sector takes the lead, constituting 30% of the disruptors. Notably, Information Technology, Life Science & Healthcare, and Automotive collectively account for 64% of the disruptors, showcasing their dominance in reshaping traditional sectors.

Sectoral Comparison:

Information Technology emerges as the top and fastest-growing sector among the disruptors, comprising 28%, nearly four times that of the Global Innovation 100. The Automotive sector, with 7 pioneering companies, claims 14% of the disruptors, nearly three times more than its representation in the Global Innovation 100.

Shift in Innovation Focus:

Over the last decade, the world’s innovation trajectory has evolved from a physical world of atoms to a digital world of bits, and now towards a “world of atoms empowered by bits.” This paradigm shift is embodied in the disruptive innovations brought forth by the Global Disruption 50.

World of Bits:

Disruption 50 participants are leveraging digital technologies to provide innovative digital offerings. Examples include DoorDash for online food delivery, Lyft for online shared transport services, Zoom redefining teleconferencing, Hyperchain Technology using blockchain for financial and energy solutions, and Snap offering a visual messaging app.

Integration of Atoms and Bits:

Another trend observed is the integration of the physical world with the digital realm. Disruption 50 companies are offering solutions that seamlessly combine hardware and software. Peloton Interactive revolutionizes fitness with workout equipment, software, and platforms. Traffic Control Technology provides end-to-end rail traffic control solutions. Beijing Horizon Information Technology offers auto-pilot computing solutions, Pateo is an end-to-end provider for the Internet of Vehicles, and Cerence pioneers AI automotive assistants with core voice technology.

Visualizing the Disruption:

Graphical representations in the report provide a visual journey into the disruption caused by the Global Disruption 50, offering a dynamic perspective on how these innovators are reshaping the established world.

The Patsnap 2023 Global Disruption 50, with their strategic focus on Information Technology, Automotive, and Life Science & Healthcare, are not merely innovators but disruptors, reshaping the world by transitioning from a physical to a digital realm and finally integrating both seamlessly. For a comprehensive analysis and deeper insights, explore our “Patsnap 2023 Global Innovation Report” and witness the transformative power of disruption redefining the future of innovation.

The post Impact of Patsnap’s 2023 Global Disruption 50 appeared first on Patsnap.

Rapid Evolution and Ambitious Growth:

Formation and Growth:

Emerging within the last 15 years, the Global Disruption 50 participants are dynamic entities rapidly cultivating remarkable technological capabilities. Unlike the established giants of the Global Innovation 100, these disruptors, on average, are around 15 years old and boast an impressive growth rate of approximately 50% per year, outpacing both global averages and the slower-growing or stagnating Global Innovation 100.

Innovation Profile:

A typical “innovation profile” of a 2023 Global Disruption 50 company is characterized by a medium technology size, averaging around 3,600 patent applications. Their technology quality is solid, reflected in an invention application percentage of 87%. Despite limited technology globalization, with patents applied for in only 19 countries/regions on average, these disruptors exhibit a strong technology influence, with each patent cited more than 8 times on average.

Comparative Analysis with Global Innovation 100:

Technological Impact:

Despite a relatively modest size and limited global coverage, the 2023 Global Disruption 50 are already demonstrating a potent technological influence, instigating profound transformations across the world. Their technology quality and influence almost match those of the established Global Innovation 100, showcasing the disruptive potential within their compact portfolios.

Invention Application Percentage:

A typical Disruption 50 company boasts an invention application percentage of 87%, aligning closely with an Innovation 100 company’s 91%, highlighting a similar commitment to high-quality innovation.

Patent Citations:

The average number of patent citations for a Disruption 50 company stands at 8.3 times, closely paralleling the Global Innovation 100’s 8.6 times. This similarity underscores the impactful nature of the disruptive technologies being developed by the rising stars.

Technological Globalization:

While the Global Disruption 50 are less technologically globalized compared to their Innovation 100 counterparts, with patents covering only 1/4th the geographic range, their focused influence is already triggering transformative shifts in targeted regions.

Visual Insights into Disruption:

The report is enriched with graphical representations, offering intuitive insights into the disruptive capabilities of the 2023 Global Disruption 50, highlighting their unique strengths and impact on the global technological landscape.

The Patsnap 2023 Global Disruption 50, though relatively nascent in their journey, are proving to be dynamic forces of innovation. With their ambitious growth, solid technological capabilities, and impactful influence, these disruptors are reshaping the innovation narrative. For a comprehensive analysis and deeper insights, explore our 2023 Global Innovation Report and witness the disruptive potential that is redefining the future of innovation.

The post Patsnap’s 2023 Disruption 50: A Closer Look at Tomorrow’s Innovators appeared first on Patsnap.

Building from the Ground Up:

Independently Forged Visions:

The majority of disruptors, a remarkable 40 out of 50, embarked on their innovation journey from independent foundations. Guided by visionary leaders with a passion to make a difference, these disruptors, including the exceptional Dutch 3D printer supplier Ultimaker, started from ground zero, challenging established players like GE and HP.

Ultimaker’s inception at the ProtoSpace FabLab in Utrecht exemplifies the potency of independent foundations, propelling them to challenge industry norms and redefine technological landscapes.

Incubated Innovations:

10% of the Global Disruption 50 trace their roots to research institutes, leveraging initial technology developed within these academic environments. Companies like Saluda Medical and QuantumCTek emerged as global pioneers in smart neuromodulation therapy and Quantum Communication, respectively, after incubation in research institutes such as Australia’s Information Communications Technology Center of Excellence and the University of Science and Technology of China.

Saluda Medical’s journey from research excellence in Australia’s ICT Center to commercialization showcases the transformative power of academic incubation in driving innovation.

Spin-offs from Tech Giants:

Another 10% of disruptors are spin-offs from established tech giants, inheriting technologies and gaining unique market advantages from their inception. Companies like Resideo, Advansix, Kioxia, SVOLT, and Cerence, with origins from entities like Honeywell, Toshiba, Great Wall Motor, and Nuance, exemplify the evolution and continuous innovation of spin-off disruptors.

Resideo and Advansix, born from the legacy of Honeywell, and Kioxia, inheriting semiconductor prowess from Toshiba, highlight the strategic advantages gained by spin-offs in the innovation landscape.

The Patsnap 2023 Global Disruption 50, with their varied origins from independent foundations, academic incubation, and spin-offs from tech giants, exemplify the diverse pathways to innovation excellence. For a comprehensive analysis and deeper insights, explore our 2023 Global Innovation Report and witness the innovative tapestry woven by disruptors redefining the future of global innovation.

The post The Origins of Patsnap’s 2023 Global Disruption 50 appeared first on Patsnap.

Global Technological Prowess:

Magnitude of Influence:

The Global Innovation 100, with around 68,000 “tech subsidiaries,” may constitute less than 2% of total global tech companies. However, their impact is colossal, contributing to 22% of the world’s invention assets, fueling 27% of global technology competition, and inspiring a remarkable 35% of the world’s technological innovations, as measured by patent citations.

Innovation Metrics:

In terms of sheer size, these 100 companies and their subsidiaries boast 3.58 million valid inventions, representing 22% of the world’s total. In the realm of technology globalization, their 1.27 million PCT filings account for 27% of the global total. The influence of their patents is undeniable, with a staggering 153 million citations, making up 35% of all patent citations worldwide.

The Current Technological Landscape:

Post-COVID Resilience:

Despite a slowdown in the pace of overall innovation in the post-COVID era, the 2023 Global Innovation 100 remain unwavering in their commitment to cutting-edge technological fields. In a recovering global economy, these companies contributed nearly 1 million patent applications in 2022, reflecting a slight downturn with a CAGR of -2.3% compared to the previous three years.

Investment in Cutting-Edge Fields:

Delving into the dynamics of the 68,000 tech subsidiaries, it is evident that the 2023 Global Innovation 100 are driving progress in cutting-edge technological domains. With 336 “high-growth” tech subsidiaries, these companies are strategically positioned in four key areas: smart grid, biomedical engineering, biopharmaceuticals, and electronic components.

Innovation in Action:

Smart Grid Revolution:

With 57 high-growth subsidiaries in the smart grid sector, companies like Huawei are spearheading innovations in new energy and smart grids, shaping the future of sustainable energy solutions.

Biomedical Engineering Advancements:

In the field of biomedical engineering, 2023 Global Innovation 100 entities like Becton Dickinson, through acquisitions like Scanwell Health, are revolutionizing home testing reagents and mobile phone-based diagnostic solutions.

Biopharmaceutical Innovations:

Takeda Pharmaceuticals, with 34 high-growth subsidiaries, is at the forefront of cutting-edge immunotherapy technology, demonstrating the transformative power of acquisitions and collaborations in the biopharmaceutical sector.

Electronic Components Revolution:

In electronic components, companies like Honeywell are exploring integrated solutions in quantum computing software and hardware through strategic mergers, exemplified by its collaboration with Cambridge Quantum.

As we navigate the dynamic landscape of innovation, the Patsnap 2023 Global Innovation 100 stand as pillars of progress, contributing significantly to global technological evolution. From redefining traditional industries to pioneering breakthroughs in cutting-edge fields, these innovators are leaving an indelible mark on the world of technology. For a comprehensive analysis and deeper insights, explore our 2023 Global Innovation Report and witness the transformative power of innovation in action.

To download the full report, click here!

The post Impact of Patsnap’s 2023 Global Innovation 100 appeared first on Patsnap.

Global Collaboration: A Technological Tapestry

Universal Collaboration:

Technological collaboration is not just common but ubiquitous among the 2023 Global Innovation 100. Almost every participant in this elite group engages in collaborative efforts with their peers, forging connections that span industries and borders.

Active Interactions:

The Global Innovation 100 actively collaborate in technology innovation, with an impressive 99 out of the 100 participants engaging in technological cooperation with others on the list. This interconnectedness underscores a global commitment to shared innovation goals.

Diverse Partnerships:

On average, each Global Innovation 100 participant maintains collaborations with 26 partners within the list. These partnerships may extend between parent companies or involve their subsidiaries. Notable leaders in collaboration include Panasonic, Siemens, and Hitachi, each boasting around 50 partners from the elite list.

Joint Patent Applications:

The collaborative efforts translate into a wealth of joint patent applications, with a staggering 85,000 patents co-invented by these visionary companies. Leaders in this realm include Toyota, Denso, and Hitachi, each contributing more than 10,000 joint patent applications to the collective innovation pool.

Divergent Collaboration Strategies:

U.S. Collaboration Trends:

Global innovation leaders from the U.S. exhibit a preference for international collaboration, with joint patent applications with overseas counterparts surpassing those with domestic partners. The collaborative efforts with international counterparts outweigh domestic collaboration by 40%.

Japanese Collaboration Dynamics:

In contrast, Japan’s Global Innovation 100 showcases a distinctive approach, prioritizing domestic technological collaboration. Joint patent applications with domestic partners are six times more prevalent than those with overseas counterparts, highlighting a preference for fostering innovation within national borders.

Global Patterns Visualized:

Engaging visual representations in the report illustrate the collaboration patterns, showcasing the intricate connections between companies and countries, providing a dynamic perspective on how innovation is fostered globally.

The Patsnap 2023 Global Innovation 100, although fierce competitors in the technological arena, are deeply interwoven in a collaborative tapestry. With active partnerships, diverse collaborations, and distinct preferences among global leaders, this interconnected brilliance sets the stage for a future where innovation knows no boundaries. For an in-depth exploration and comprehensive analysis, refer to our 2023 Global Innovation Report and witness the collaborative spirit shaping the forefront of global innovation.

The post Navigating the Collaborative Web of Patsnap’s 2023 Global Innovation 100 appeared first on Patsnap.

Jump to…

The Regional Landscape

Global Footprint and Patent Coverage

Industries Driving Innovation

Global Innovation 100: The Regional Landscape

Hailing from 15 countries and spanning 11 diverse industries, the Global Innovation 100 showcase a remarkable global reach. With headquarters distributed across countries such as the U.S., Japan, Germany, China, Switzerland, and the United Kingdom, these innovators represent a diverse array of technological prowess.

Region-wise, the majority of the Global Innovation 100 are rooted in the U.S. and Japan, comprising nearly two-thirds of the list. On a continental level, Asia dominates with 40%, driven primarily by Japan. North America, entirely represented by the U.S., and Europe, with a balanced distribution across nine countries, follow closely.

Global Footprint and Patent Coverage:

Surprisingly, the Global Innovation 100 extend their reach far beyond their headquarters. With 68,000 “tech subsidiaries” operating globally, these companies have established a formidable presence in 181 countries, filing a staggering 20.8 million patent applications in over 159 countries.

Asia, North America, and Europe: A Comparative Analysis:

Diving into the characteristics of the Global Innovation 100, distinct trends emerge across Asia, North America, and Europe.

Asia’s Technological Dominance:

• Asia-based companies lead in Technology Size, boasting an average of 280,000 patent applications each, about 1.5 times that of Europe and twice that of North America.
• Top contributors include Panasonic, Samsung Electronics, and Hitachi, filing 1.06 million, 880,000, and 730,000 patents respectively.

North America’s Innovation Influence:

• North American companies excel in Technology Influence, with an average citation of 12.6 times per patent, more than double that that of the Global Innovation 100 from Europe and Asia.
• U.S.-based companies such as Medtronic, Oracle, and Boston Scientific lead the pack with patents cited 49 times, 30 times, and 30 times on average, respectively.

Europe’s Global Technological Reach:

• European companies exhibit a higher level of Technology Globalization, filing patents in an average of 101 countries, surpassing other continents.
• Notable contributors include AstraZeneca, Novartis, Bayer, Sanofi, BASF, and Shell, filing in over 120 countries.

Industries Driving Innovation:

The Global Innovation 100 are spread across 11 industries, with Life Science & Healthcare, Chemicals & Materials, Electronics, and Machinery & Equipment taking the lead. Together, these four sectors account for nearly 70% of the innovators, showcasing a concentration of technological advancement in critical areas such as healthcare, materials, electronics, and machinery.

In conclusion, the Patsnap 2023 Global Innovation 100 emanate from diverse corners of the globe, driving technological progress and innovation in pivotal industries. For a comprehensive analysis and further insights, refer to our 2023 Global Innovation Report. Explore the trends, discover the innovators, and join us in celebrating the global spirit of innovation that defines the year 2023.

The post The Origins of Patsnap’s 2023 Global Innovation 100 appeared first on Patsnap.

Download it now to learn about:

• The first approved drugs in May 

• New drug analysis 

• Global drugs under expedited review pathway in May 

• Analysis of selected ERP drugs 

May 2023 Global Innovative Drug Report Overview

1.) Drugs Approved in May

In May 2023, a total of 18 drugs received global approval, representing a diverse range of therapeutic categories. These include:

• 4 Small molecule drugs (SMD)
• 4 Monoclonal antibodies (mAb)
• 2 Prophylactic vaccines
• 2 Allergen extracts
• 1 Blood component
• 1 Gene therapy
• 1 Bispecific antibody
• 1 Enzyme
• 1 Fusion protein
• 1 Synthetic peptide

2.) Comprehensive Analysis of Newly Introduced Medications 

This report also offers a comprehensive analysis of five recently approved drugs, providing valuable insights into their profiles and impact. Let’s delve into the in-depth analysis of Benegrastim, one of the featured drugs, which encompasses the following comprehensive details:

3.) Global Drugs Under Expedited Review Pathway in May 

In May 2023, there were 57 drugs worldwide undergoing Expedited Review pathways. These included:

• 32 Orphan Drug designations
• 12 Fast Track designations
• 5 Priority reviews
• 4 Breakthrough Therapy designations
• 2 Regenerative Medicine Advanced Therapy designations
• 1 Innovative Licensing and Access Pathway (ILAP)
• 1 Accelerated Approval

These designations and pathways aim to accelerate the evaluation and approval process, ensuring timely access to innovative treatments for patients in need.

4.) Analysis of Selected ERP Drugs 

Within this report, we selected five drugs under Expedited Review pathways for detailed analysis. Now, let’s explore the report content focused on Spesolimab, which provides an in-depth examination of the following key details:

Gain Access to the Comprehensive Report for FREE – Download Now! If you aren’t registered for Synapse (registration is required to download the report), click here to register for free.

PatSnap Synapse Database: An Overview and Key Features

Discover the innovative PatSnap Synapse database – an AI-powered platform that provides intuitive interfaces, curated content, and access to massive information sources. With integrated access to company data, diseases, targets, clinical studies, biological and chemical entities, our platform offers a powerful search and association experience. Sign up for free today and experience the benefits for yourself!

R&D Decision Makers

Our mission is to empower R&D decision makers with swift access to accurate and connected data, facilitating their understanding of emerging technology trends, competitive landscapes, and partnership opportunities. By providing comprehensive insights, our platform helps decision makers to navigate and steer the direction of innovation with confidence.

Business Development Professionals 

We offer a comprehensive database that covers the drug pipeline and investment history for over 320,000 life science organizations. This invaluable resource allows you to make informed decisions regarding potential partnerships or acquisition targets with confidence. Gain access to our extensive database and unlock the insights you need to drive your business forward.

Pharmaceutical Analyst 

Our platform is designed to accelerate the research process for pharmaceutical analysts by leveraging a wealth of connected data, including drug approvals, clinical trials, patents, non-patent literature, and news. With Synapse, users gain a comprehensive 360-degree view of the competitive and technological landscape, empowering them to make informed decisions quickly and efficiently. Discover the power of Synapse and revolutionize your research today.

Copyright Statement: This report is the sole property of Patsnap and is protected under copyright laws. Any reproduction, excerpting, or other use of this report without explicit authorization from Patsnap is strictly prohibited. Authorized products must be used within the scope of authorization and must include a clear indication of the source. Patsnap reserves the right to investigate any violations of this statement and pursue legal action as necessary. For inquiries regarding authorization, please contact phs@patsnap.com.

The post May 2023 Global Innovative Drug Report appeared first on Patsnap.

The recently published Global Innovative Drug Report, based on data from the PatSnap Synapse database, consists of three parts:

1. Global Approved Drugs
2. Global Drugs under Expedited Review Pathway
3. Global Drug Clinical Progression

The report offers a comprehensive overview of the latest advancements in the pharmaceutical industry.

Global Innovative Drug Report Overview

1.) March 2023 Global Drug Approvals:

During March of 2023, a total of 41 drugs were approved on a global scale, encompassing a diverse range of drug types. These include 21 Small Molecule drugs, 4 Vaccines, 3 Antibody drugs, 3 Synthetic Peptides, 2 Enzymes, 2 Biosimilars, 1 Antibody Drug Conjugate (ADC), 1 Bispecific Antibody, 1 Fusion Protein, 1 Immunoglobulin, 1 Cell Therapy, and 1 Fc Fragment.

2.) March 2023 Global Drugs Subject to Expedited Review:

During March 2023, the global pharmaceutical industry had a total of 53 drugs undergoing expedited review pathway, comprising various types of designations. Notably, 32 drugs had received Orphan Drug Designation, while 6 were designated as Fast Track, and 4 were granted Breakthrough Therapy Designation. Additionally, 4 drugs obtained Conditional Marketing Approval, 3 received Emergency Use Authorization, 1 underwent Priority Review, 1 was granted PRIME designation, 1 received Rare Pediatric Disease designation, and 1 achieved Accelerated Approval.

3.) March 2023 Global Clinical Progress of Drugs:

During March 2023, a total of 3352 news items related to global drug clinical progress were available for retrieval from the Synapse database. From this comprehensive collection, 10 noteworthy news items were handpicked, including Clinical Reviews and Approvals, Phase I, II, and III Results, as well as Marketing Authorization Applications. These 10 selected news items represent the most significant and influential developments in the pharmaceutical industry during the month of March 2023.

Gain Access to the Comprehensive Report for FREE – Download Now! If you aren’t registered for Synapse (registration is required to download the report), click here to register for free.

PatSnap Synapse Database: An Overview and Key Features

Discover the innovative PatSnap Synapse database – an AI-powered platform that provides intuitive interfaces, curated content, and access to massive information sources. With integrated access to company data, diseases, targets, clinical studies, biological and chemical entities, our platform offers a powerful search and association experience. Sign up for free today and experience the benefits for yourself!

R&D Decision Makers

Our mission is to empower R&D decision makers with swift access to accurate and connected data, facilitating their understanding of emerging technology trends, competitive landscapes, and partnership opportunities. By providing comprehensive insights, our platform helps decision makers to navigate and steer the direction of innovation with confidence.

Business Development Professionals 

We offer a comprehensive database that covers drug pipeline and investment history for over 320,000 life science organizations. This invaluable resource allows you to make informed decisions regarding potential partnerships or acquisition targets with confidence. Gain access to our extensive database and unlock the insights you need to drive your business forward.

Pharmaceutical Analyst 

Our platform is designed to accelerate the research process for pharmaceutical analysts by leveraging a wealth of connected data, including drug approvals, clinical trials, patents, non-patent literature, and news. With Synapse, users gain a comprehensive 360-degree view of the competitive and technological landscape, empowering them to make informed decisions quickly and efficiently. Discover the power of Synapse and revolutionize your research today.

Copyright Statement: This report is the sole property of PatSnap and is protected under copyright laws. Any reproduction, excerpting, or other use of this report without explicit authorization from PatSnap is strictly prohibited. Authorized products must be used within the scope of authorization and must include a clear indication of the source. PatSnap reserves the right to investigate any violations of this statement and pursue legal action as necessary. For inquiries regarding authorization, please contact phs@patsnap.com.

The post March 2023 Global Innovative Drug Report appeared first on Patsnap.